U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Soft steroids having anti-inflammatory activity

Patent 4996335 Issued on February 26, 1991. Estimated Expiration Date: Icon_subject February 26, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3558675

3856828

Pharmaceutical compositions of 6଱,9଱-difluoro-androst-4-ene-17ଲ-carboxylates and derivatives thereof
Patent #: 4093721
Issued on: 06/06/1978
Inventor: Phillipps, et al.

Corticoid 17-(alkyl carbonates) and processes for their preparation
Patent #: 4242334
Issued on: 12/30/1980
Inventor: Stache ,   et al.

Thio etianic acid derivatives
Patent #: 4263289
Issued on: 04/21/1981
Inventor: Edwards

Corticoid-17-(alkyl carbonates) and process for their manufacture Patent #: 4377575
Issued on: 03/22/1983
Inventor: Stache ,   et al.

Inventor

Assignee

Application

No. 807034 filed on 12/09/1985

US Classes:

552/610, Acyclic carbon bonded directly at the 17 beta-position of the cyclopentanohydrophenanthrene ring system (e.g., etiocholanic acids, 17 cyanoetiocholanes, 17-aldehydrostanes, etc.)552/611, Exactly one oxygen bonded directly to the cyclopentanohydrophenanthrene ring system (e.g., 3-keto-etiocholanic acids, etc.)552/612Three or more oxygens bonded directly to the cyclopentanohydrophenanthrene ring system

Examiners

Primary: Friedman, Stanley J.
Assistant: Criares, Theodore J.

Attorney, Agent or Firm

International Classes

C07J 003/00
A01N 043/50

Abstract

The invention provides novel soft steroidal anti-inflammatory agents, pharmaceutical compositions containing said agents, and methods of administering same to mammals in the treatment of inflammation. Preferred compounds of the invention include haloalkyl 17଱-alkoxycarbonyloxy-11ଲ-hydroxyandrost-4-en-3-one-17ଲ-ca rboxylates and the corresponding Ɗ1,4 compounds, optionally bearing 6଱- and/or 9଱-fluorine and 16଱- or 16ଲ-methyl substituents. Especially preferred compounds include haloalkyl 17଱-alkoxycarbonyloxy-9଱-fluoro-11ଲ-hydroxy-16-methylandr osta-1,4-dien-3-one-17ଲ-carboxylates.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?